Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
08/1999
08/11/1999EP0934409A2 Diabetes-mediating proteins and therapeutic uses thereof
08/11/1999EP0934404A1 Inhibition of proliferation of cells
08/11/1999EP0934403A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation
08/11/1999EP0934342A1 Composition containing chitosan
08/11/1999EP0934340A1 Novel compounds
08/11/1999EP0934336A1 Novel compounds
08/11/1999EP0934335A1 Novel compounds
08/11/1999EP0934083A1 Improved vaccines
08/11/1999EP0934082A2 Process for producing biologically active polymer nanoparticle-nucleic acid conjugates
08/11/1999EP0933997A1 Methods and compositions for liver specific delivery of therapeutic molecules using recombinant aav vectors
08/11/1999EP0789706A4 Sugar modified nucleosides and their use for synthesis of oligonucleotides
08/11/1999EP0785987B1 Flow through electroporation apparatus and method
08/11/1999EP0699240B1 Gibbon ape leukemia virus-based retroviral vectors
08/11/1999CN1225685A Avian polynucleotide vaccine formula for anti birds' disease
08/11/1999CN1225684A Avian polynucleotide vaccine formula for anti pig's diseases
08/11/1999CN1225682A Method and compositions for regulating T cell subsets by modulating transcription facter activity
08/11/1999CN1225640A Hodgkin disease associated molecules and uses thereof
08/11/1999CN1225590A Peptides with increased binding affinity for HLA molecules
08/11/1999CN1225367A Bond partner, and use for sieving inhibitor and diagnosis and treatment of disease
08/11/1999CN1225277A Tech. for anti and treating cancer using gene clone tech.
08/10/1999US5935936 Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules
08/10/1999US5935935 Adenoviral vectors for treatment of hemophilia
08/10/1999US5935934 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy
08/10/1999US5935852 The present invention relates to a family of proteins designated as cerberus, which appears to be a pioneer protein, with a 9 cysteine residue pattern, which is present in the embryo.
08/10/1999US5935849 Methods and compositions of growth control for cells encapsulated within bioartificial organs
08/10/1999US5935835 The invention relates to novel polynucleotides and polypeptides of the family of cdc-regulatory kinases, hereinafter referred to as human myt-1 kinase.
08/10/1999US5935830 Site-directed mutagenesis by forming triple helix with double-stranded dna and oligonucleotide with electrophilic group, electrophilic group causes modification of dna nucleotide, then replication causes mutation
08/10/1999US5935821 Nucleotide sequence that codes polypeptide anti-idiotype immunoglobulin a ganglioside useful in the suppression of cancer and reduction of recurrence; anticarcinogenic agents
08/10/1999US5935820 Polynucleotides encoding vascular endothelial growth factor 2
08/10/1999US5935816 Isolated polynucleotide and process for producing lysyl trna synthetase using host cells and vectors; use is to screen for antibacterial compounds
08/10/1999US5935814 G-protein coupled receptor family polypeptides, referred to as hfgan72y, altered nucleic acid seqences encoding it and recombinant materials and methods for its production; use in design of protocols and treatment of various infections
08/10/1999US5935810 Polynucleotide sequences coding a human weight regulatory protein; therapy and diagnostic tool for eating disorders cachexia; antisense agents; gene therapy
08/10/1999US5935803 Methods to identify immunomodulators using cognate interaction of PKC-theta
08/10/1999US5935569 Genetic anticancer vaccine
08/10/1999US5935568 Gene therapy for effector cell regulation
08/10/1999US5935565 Method for increasing the level of stem cells in peripheral blood
08/10/1999US5935553 Methods of preparing gas-filled liposomes
08/09/1999CA2245999A1 Novel compounds
08/05/1999WO1999038992A1 Synergism between thymidine kinase gene therapy and topoisomerase i and topoisomerase ii inhibitors
08/05/1999WO1999038964A2 Promoter regions of the mouse and human telomerase rna component genes
08/05/1999WO1999038963A1 Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth
08/05/1999WO1999038955A2 Mutant herpes simplex viruses and uses thereof
08/05/1999WO1999038954A1 A universal immunomodulatory cytokine-expressing bystander cell line and related compositions and methods of manufacture and use
08/05/1999WO1999038952A2 Cells or tissues with increased protein factors and methods of making and using same
08/05/1999WO1999038881A1 67 human secreted proteins
08/05/1999WO1999038880A1 Genetic immunization with nonstructural proteins of hepatitis c virus
08/05/1999WO1999038821A2 Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications
08/05/1999WO1999028341A3 Maintenance of smooth muscle integrity by morphogenic proteins
08/05/1999WO1999025843A3 Human checkpoint kinase, hcds1, compositions and methods
08/05/1999WO1999024559A3 Nuclear targeting by means of streptococcal protein h
08/05/1999WO1999023216A3 Hyperthermic inducible expression vectors for gene therapy and methods of use thereof
08/05/1999WO1999020643A9 Using polyamide nucleic acid oligomers to engender a biological response
08/05/1999WO1999019359A8 Cellular receptor for hiv-1 vpr essential for g2/m phase transition of the cell cycle
08/05/1999WO1999014226A3 Bi- and tri-cyclic nucleoside, nucleotide and oligonucleotide analogues
08/05/1999WO1999011292A9 Compositions and methods for treating arthritis utilizing gene therapy
08/05/1999WO1999009186A3 Polypeptide nucleic sequences exported from mycobacteria, vectors comprising same and uses for diagnosing and preventing tuberculosis
08/05/1999WO1999006545A3 Composition and method for the detection of diseases associated with amyloid-like fibril or protein aggregate formation
08/05/1999WO1999006059A3 Methods and compositions relating to no-mediated cytotoxicity
08/05/1999WO1997016206A8 Bladder nuclear matrix proteins and their use in detecting and treating cell proliferative disorders
08/05/1999CA2319710A1 Oligonucleotide sequences complementary to thioredoxin or thioredoxin reductase genes and methods of using same to modulate cell growth
08/05/1999CA2319669A1 Mutant herpes simplex viruses and uses thereof
08/05/1999CA2319129A1 67 human secreted proteins
08/05/1999CA2318744A1 Genetic immunization with nonstructural proteins of hepatitis c virus
08/04/1999EP0932701A1 STRUCTURAL AND FUNCTIONAL CONSERVATION OF THE C. ELEGANS CLOCK GENE clk-1
08/04/1999EP0932694A2 Aav4 vector and uses thereof
08/04/1999EP0932693A1 Alphavirus-retrovirus vectors
08/04/1999EP0932687A1 Novel human phosphorylase kinase gamma subunit
08/04/1999EP0932686A2 Telomerase reverse transcriptase
08/04/1999EP0932681A2 Compounds and methods for immunotherapy and diagnosis of tuberculosis
08/04/1999EP0932679A1 METHODS AND COMPOSITIONS FOR DELIVERY AND EXPRESSION OF INTERFERON-$g(a) NUCLEIC ACIDS
08/04/1999EP0932678A2 A family of genes encoding apoptosis-related peptides, peptides encoded thereby and methods of use thereof
08/04/1999EP0932675A2 Epidermal differentiation factor
08/04/1999EP0932674A1 A NOVEL MAMMALIAN GENE, bcl-w, BELONGS TO THE bcl-2 FAMILY OF APOPTOSIS-CONTROLLING GENES
08/04/1999EP0932671A2 Extension of a protein-protein interaction surface to inactivate the function of a cellular protein
08/04/1999EP0932420A1 Drug delivery using terminal complement components
08/04/1999EP0932418A2 Method for recombinant adeno-associated virus-directed gene therapy
08/04/1999EP0932391A2 Fusogenic liposome composition and method
08/04/1999EP0871644A4 Platelet-endothelial cell adhesion molecule-1 compositions and methods
08/04/1999EP0665739B1 Morphogen-induced periodontal tissue regeneration
08/04/1999EP0642761B1 Ct system for quantitatively determining bone mineral mass
08/04/1999EP0585242B1 Wound healing
08/04/1999CN1225131A Method for treating amyotrophic lateral sclerosis
08/04/1999CN1225019A Inhibition of Ii synthesis
08/04/1999CN1225007A Cationic virosomes as transfer system for genetic material
08/03/1999US5932779 Transgenic mouse with mutation in endogenous melanocortin-4-receptor gene; obesity, anorexia, and cachexia treatment
08/03/1999US5932701 ribA
08/03/1999US5932556 Using an oligonucleotide
08/03/1999US5932540 Vascular endothelial growth factor 2
08/03/1999US5932476 Cloning of chicken anemia virus DNA
08/03/1999US5932470 Ectoparasite saliva proteins and apparatus to collect such proteins
08/03/1999US5932461 Seryl tRNA synthetase from Staphylococcus aureus
08/03/1999US5932459 Artificial tissues, methods for the production and the use thereof
08/03/1999US5932422 Determining whether transformed mammalian cell will respond to drug by measuring level of enzyme and comparing to level in normal cell, increased level of enzyme indicates resistance; diagnosing resistant tumor cells
08/03/1999US5932241 Cationic lipid DNA complexes for gene targeting
08/03/1999US5932210 Partial or total deletion of the adenoviral protein ix dna and having a gene encoding a foreign protein or a functional fragment or mutant thereof.
07/1999
07/30/1999CA2246001A1 Novel compounds
07/29/1999WO1999037818A1 Novel molecules of the tnf receptor superfamily and uses therefor
07/29/1999WO1999037788A2 Diagnosis and treatment of aur1 and/or aur2 related disorders
07/29/1999WO1999037781A1 Mutants of il-16, processes for their production, and their use
07/29/1999WO1999037780A1 Expression of the insl4 gene in human embryonic bone tissues and applications
1 ... 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 ... 870